This topic contains a solution. Click here to go to the answer

Author Question: The health care provider has prescribed famotidine (Pepcid) 1 mg/kg/day divided bid for a child with ... (Read 61 times)

kamilo84

  • Sr. Member
  • ****
  • Posts: 495
The health care provider has prescribed famotidine (Pepcid) 1 mg/kg/day divided bid for a child with gastroesophageal reflux disease. The child weighs 33 lb. The nurse is preparing to administer the 0900 dose.
 
  Calculate the dose the nurse should administer in milligrams. Record your answer using one decimal place.
  _______________

Question 2

The health care provider has prescribed metronidazole (Flagyl) 30 mg/kg a day divided q 6 hours for a child with peptic ulcer disease. The child weighs 110 lb. The nurse is preparing to administer the 1200 dose.
 
  Calculate the dose the nurse should administer in mg. Record your answer in a whole number.
  ______________



Related Topics

Need homework help now?

Ask unlimited questions for free

Ask a Question
Marked as best answer by a Subject Expert

TINA

  • Sr. Member
  • ****
  • Posts: 336
Answer to Question 1

7.5

Answer to Question 2

375




kamilo84

  • Member
  • Posts: 495
Reply 2 on: Jun 28, 2018
Excellent


fatboyy09

  • Member
  • Posts: 358
Reply 3 on: Yesterday
Gracias!

 

Did you know?

In the United States, an estimated 50 million unnecessary antibiotics are prescribed for viral respiratory infections.

Did you know?

In women, pharmacodynamic differences include increased sensitivity to (and increased effectiveness of) beta-blockers, opioids, selective serotonin reuptake inhibitors, and typical antipsychotics.

Did you know?

When intravenous medications are involved in adverse drug events, their harmful effects may occur more rapidly, and be more severe than errors with oral medications. This is due to the direct administration into the bloodstream.

Did you know?

If all the neurons in the human body were lined up, they would stretch more than 600 miles.

Did you know?

Bisphosphonates were first developed in the nineteenth century. They were first investigated for use in disorders of bone metabolism in the 1960s. They are now used clinically for the treatment of osteoporosis, Paget's disease, bone metastasis, multiple myeloma, and other conditions that feature bone fragility.

For a complete list of videos, visit our video library